RBC Capital Starts BioMarin Pharmaceutical (BMRN) at Outperform
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $65.02 +0.60%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
RBC Capital initiates coverage on BioMarin Pharmaceutical (NASDAQ: BMRN) with an Outperform. PT $36.00.
For more ratings news on BioMarin Pharmaceutical click here and for the rating history of BioMarin Pharmaceutical click here.
Shares of BioMarin Pharmaceutical closed at $30.35 yesterday.
For more ratings news on BioMarin Pharmaceutical click here and for the rating history of BioMarin Pharmaceutical click here.
Shares of BioMarin Pharmaceutical closed at $30.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
- Nomura/Instinet Resumes Kobe Bussan Co Ltd (3038:JP) at Neutral
- Nomura/Instinet Starts Astra Agro Lestari Tbk PT (AALI:IJ) (AAGRY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
